Bangladesh vs Libya: Cause of death, by non-communicable diseases, male
Bangladesh
58.8%
in 2021
Libya
58.1%
in 2021
Bangladesh rank
98th
Libya rank
100th
Cause of death, by non-communicable diseases, male over time
- Bangladesh
- Libya
How they compare
Bangladesh currently reports 58.8% against 58.1% in Libya, a difference of 0.7%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Libya ahead.
Bangladesh ranks 98th and Libya ranks 100th of 185 countries.
Across the 3 decades both report, Bangladesh averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Bangladesh | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.3% | 63.7% | 18.4% | Libya |
| 2010s | 62.6% | 66.8% | 4.2% | Libya |
| 2020s | 61.3% | 61.2% | 0.1% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Bangladesh or Libya?
- Bangladesh, at 58.8% against 58.1% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Bangladesh and Libya?
- 0.7%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Bangladesh and Libya rank globally for cause of death, by non-communicable diseases, male?
- Bangladesh ranks 98th and Libya ranks 100th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.